Crossmark

Cyclosporine/methotrexate versus tacrolimus/methotrexate with or without anti-thymocyte globulin as GVHD prophylaxis in adult patients with aplastic anemia

Crossref DOI link: https://doi.org/10.1007/s00277-020-04290-1

Published Online: 2020-10-09

Published Print: 2021-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Onishi, Yasushi https://orcid.org/0000-0003-0032-6994
Mori, Takehiko

Yamazaki, Hirohito

Takenaka, Katsuto

Yamaguchi, Hiroki

Shingai, Naoki

Ozawa, Yukiyasu

Iida, Hiroatsu

Ota, Shuichi

Uchida, Naoyuki

Miyamoto, Toshihiro

Katayama, Yuta

Kato, Jun

Yoshioka, Satoshi

Onizuka, Makoto

Ichinohe, Tatsuo

Atsuta, Yoshiko

,
License Information

Text and Data Mining valid from 2020-10-09

Version of Record valid from 2020-10-09
More Information

Article History

Received: 21 July 2020

Accepted: 28 September 2020

First Online: 9 October 2020

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

: Informed consent was obtained from all individual participants included in the study.

Document is current

Any future updates will be listed below